Insmed (INSM) Other Working Capital Changes (2010 - 2026)
Insmed (INSM) recorded quarterly Other Working Capital Changes of -$12.6 million in Q1 2026, down 148.02% quarter-over-quarter from $26.2 million in Q4 2025, and down 174.34% on a YoY basis from $16.9 million in Q1 2025.
Insmed (INSM) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Insmed's Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$12.6 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 174.34% year-over-year to -$12.6 million; the TTM figure through Mar 2026 stood at $23.9 million (up 102.63% YoY), while the FY2025 annual figure was $53.4 million, up 276.75% from the prior year.
- Other Working Capital Changes was -$12.6 million for Q1 2026 at Insmed, down from $26.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $26.2 million in Q4 2025 to a low of -$12.6 million in Q1 2026.
- Historically, Other Working Capital Changes has averaged $3.0 million across 5 years, with a median of $1.0 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes plunged 379.36% in 2023, then surged 1036.91% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$722000.0 in 2022, then tumbled by 379.36% to -$3.5 million in 2023, then increased by 19.13% to -$2.8 million in 2024, then soared by 1036.91% to $26.2 million in 2025, then slumped by 148.02% to -$12.6 million in 2026.
- The last three Other Working Capital Changes figures came in at -$12.6 million (Q1 2026), $26.2 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.59 Mn |
| Mar 31, 2026 | -12.59 Mn |
| Dec 31, 2025 | 26.22 Mn |
| Dec 31, 2025 | 26.22 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 6.53 Mn |
| Mar 31, 2025 | 16.94 Mn |
| Mar 31, 2025 | 16.94 Mn |
| Dec 31, 2024 | -2.80 Mn |
| Dec 31, 2024 | -2.80 Mn |
| Sep 30, 2024 | -842,000.00 |
| Sep 30, 2024 | -842,000.00 |
| Jun 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | -1.51 Mn |
| Mar 31, 2024 | 19.33 Mn |
| Mar 31, 2024 | 19.33 Mn |
| Dec 31, 2023 | -3.46 Mn |
| Dec 31, 2023 | -3.46 Mn |